Type of information: Company acquisition
Acquired company: sanaplasma AG (Switzerland)
Acquiring company: Shire (UK - USA)
- • On September 6, 2018, Shire announced the acquisition of sanaplasma AG, a source plasma collection company headquartered in Switzerland. The acquisition of sanaplasma AG is expected to increase Shire’s access to plasma in the longer term and add to its European plasma collection network, complementing existing core capabilities in plasma supply and manufacturing.
- sanaplasma AG is a privately-owned company focused on source plasma collection through its operation of 14 European plasmapheresis centres; 11 in the Czech Republic and three in Hungary.Plasma is essential to the manufacture of immunoglobulin therapies that help treat patients living with certain rare immunological diseases.
- Immunology is Shire’s largest franchise, with 18% growth on a pro-forma basis in 2017 to $4.4 billion in product sales, primarily driven by increased global demand for subcutaneous and intravenous immunoglobulin brands. sanaplasma's acquisition is expected to support the growth of the Immunology business and help meet the needs of patients around the world.